UnitedHealth raises 2026 earnings guidance as lower costs drive Q3 earnings beat

UnitedHealth Group (UNH) shares rose more than 4% in premarket trading on Tuesday after the largest U.S. health insurer reported better-than-expected third-quarter results and raised its full-year 2026 earnings guidance for the third time this year.

The results also lifted shares of UnitedHealth’s (UNH) peers, including Humana (HUM), CVS Health (CVS), Centene (CNC), Alignment Healthcare (ALHC), and Elevance Health (ELV).

UnitedHealth lifted its full-year 2026 adjusted earnings outlook to at least $20.50 per share, which is above the consensus estimate of $19.87 and up from a previous range of $19.50 to $20.

For the third quarter, the Eden Prairie, Minnesota-based managed care giant reported adjusted earnings of $4.69 per share, beating analyst estimates by $0.55. Revenue came in at $112.7B, down 0.4% year over year but ahead of consensus expectations by $1.21B.

By segment, UnitedHealthcare, the company’s insurance unit, reported third-quarter revenue of $86.3B, down from $87.1B in the year-earlier period. Optum Health revenue fell 10% Y/Y to $22.9B, reflecting a reduction in value-based care patients served in markets where the business lacked sufficient value-based care presence to sustain its clinicians.

The stronger quarter was supported by lower medical costs relative to premium revenue. UnitedHealth’s medical care ratio (MCR) fell to 88.4% from 89.9% a year earlier, meaning medical expenses consumed a smaller share of premium revenue, leaving more available for administrative costs and profit. The ratio also benefited from $610M in net favorable prior-period reserve development related to 2026 dates of service.

The year-over-year decline in the MCR reflected medical cost management initiatives, benefit design changes, pricing discipline, and care delivery improvements focused on affordability and integrated value-based care.